Jan. 19 (Bloomberg) -- Jeffrey Kraws, chief executive officer and co-founder of Crystal Research Associates, talks with Bloomberg's Deirdre Bolton about the investment appeal of companies that make generic drugs.
Kraws also discusses the outlook for President-elect Barack Obama's health-care policy and his recommendation of Pfizer Inc., Johnson & Johnson, Aastrom Biosciences Inc. and Teva Pharmaceutical Industries Ltd.
Interesting and informative interview.
wyllieohagan 2 years ago